Trilateral patent office meeting

Patent protection for structural genomics-related inventions

Vinarov SD; J Struct Funct Genomics; 2003;4(2-3):191-209

Recently there have been some important developments with respect to the patentability of inventions in the field of structural genomics. The leaders of the European Patent Office (EPO), Japan Patent Office (JPO) and the United States Patent Office (USPTO) came together for a trilateral meeting to conduct a comparative study on protein 3-dimensional (3-D) structure related claims in an effort to come to a mutual understanding about

Patent protection for protein structure analysis

Shimbo I, Nakajima R, Yokoyama S, Sumikura K.; Nat Biotechnol; 2004 Jan;22(1):109-12

Three national patent offices have consulted on patents that cover protein three-dimensional structural data and pharmacophores, with significant implications for the biotechnology industry.

HIV proteins - summary

WO/2007/030637A2	HIV GP120 CRYSTAL STRUCTURE AND ITS USE TO IDENTIFY IMMUNOGENS The present disclosure relates to stabilized forms of the HIV gpl20 envelope protein in complex with the broadly neutralizing CD4-binding site antibody bl2, to crystalline forms of the stabilized...
WO/2007/030518A2	CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS AND TRIGGERING HIV-1 ENVELOPE TO REVEAL CRYPTIC V3-LOOP EPITOPES Stabilized forms of gpl20 polypeptide, nucleic acids encoding these stabilized forms, vectors comprising these nucleic acids, and methods of using these polypeptides, nucleic acids, vectors and...
WO/2002/034909A2	ENGINEERED CHIMERA OF HIV PROTEIN FRAGMENTS AND USES THEREOF The subject invention encompasses novel proteins related to the human immunodeficiency virus (HIV−1) gp41 protein and to methods of use thereof. For example, the proteins may be utilized in the...